These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 7515704

  • 1. Alternative perioperative anticoagulation monitoring during cardiopulmonary bypass in aprotinin-treated patients.
    Huyzen RJ, Harder MP, Huet RC, Boonstra PW, Brenken U, van Oeveren W.
    J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):153-6. PubMed ID: 7515704
    [Abstract] [Full Text] [Related]

  • 2. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study.
    Dietrich W, Dilthey G, Spannagl M, Jochum M, Braun SL, Richter JA.
    Anesthesiology; 1995 Oct; 83(4):679-89; discussion 29A-30A. PubMed ID: 7574046
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of low doses of aprotinin on clotting times activated with celite and kaolin.
    Farooqi N, De Hert S, Vlaeminck R, De Bakker A, Govaerts E, Vermeyen K.
    Acta Anaesthesiol Belg; 1993 Oct; 44(3):87-92. PubMed ID: 7508668
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The prolonged activated clotting time (ACT) with aprotinin depends on the type of activator used for measurement.
    Wendel HP, Heller W, Gallimore MJ, Bantel H, Müller-Beissenhirtz H, Hoffmeister HE.
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):41-5. PubMed ID: 7681331
    [Abstract] [Full Text] [Related]

  • 8. The activated clotting time in cardiac surgery: should Celite or kaolin be used?
    De Vries AJ, Lansink-Hartgring AO, Fernhout FJ, Huet RCG, van den Heuvel ER.
    Interact Cardiovasc Thorac Surg; 2017 Apr 01; 24(4):549-554. PubMed ID: 28108578
    [Abstract] [Full Text] [Related]

  • 9. Monitoring of anticoagulation in aprotinin-treated patients during heart operation.
    Tabuchi N, Njo TL, Tigchelaar I, Huyzen RJ, Boonstra PW, van Oeveren W.
    Ann Thorac Surg; 1994 Sep 01; 58(3):774-7. PubMed ID: 7524456
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro effects of aprotinin on activated clotting time measured with different activators.
    Wang JS, Lin CY, Hung WT, Thisted RA, Karp RB.
    J Thorac Cardiovasc Surg; 1992 Oct 01; 104(4):1135-40. PubMed ID: 1383640
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Aprotinin does not prolong the Sonoclot aprotinin-insensitive activated clotting time.
    Dong Y, Nuttall GA, Oliver WC, Agarwal S, Ereth MH.
    J Clin Anesth; 2007 Sep 01; 19(6):424-8. PubMed ID: 17967670
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of temperature and aprotinin during cardiopulmonary bypass on three different methods of activated clotting time measurement.
    Machin D, Devine P.
    J Extra Corpor Technol; 2005 Sep 01; 37(3):265-71. PubMed ID: 16350378
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.